Close Menu

NEW YORK (GenomeWeb) – With its recently released cellular identification and extraction platform, liquid biopsy startup RareCyte is now turning its eyes to the tissue biopsy space as well. RareCyte hopes to offer its new PickSeq workflow as a method for RNA-driven biomarker discovery in cancer tissues, as well as any situation that requires correlation between protein biomarkers with DNA- or RNA-level analysis. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

Researchers have identified a gene involved in how people determine when to urinate.

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.